Self-Stigma Linked to HbA1c in Adults With Type 1 Diabetes

WEDNESDAY, Jan. 25, 2023 (HealthDay News) -- For adults with type 1 diabetes, there is a significant association between self-stigma and hemoglobin A1c (HbA1c), according to a study published online Jan. 25 in the Journal of Diabetes Investigation.
Shoko Hamano, from Asahi Life Foundation in Tokyo, and colleagues examined the correlation between self-stigma and HbA1c in Japanese people with type 1 diabetes in a cross-sectional study. Outpatients with type 1 diabetes aged 18 years and older completed questionnaires using nine items from the Japanese version of the Self-Stigma Scale.
The final analysis excluding participants with incomplete answers and laboratory data included 109 participants. The researchers found a significant positive association between self-stigma and HbA1c after adjustment for age, sex, employment status, body mass index, duration of diabetes, and insulin secretion (β = 0.05).
"We focused on this issue through clinical experiences with people with type 1 diabetes, whose glycemic management improved markedly by social supports of eliminating diabetes-related stigma. Although the finding of an association between self-stigma and HbA1c is significant, further longitudinal research is required to determine whether self-stigma leads to suboptimal HbA1c," a coauthor said in a statement. "This research does support and highlight the importance of eliminating self-stigma when treating people with type 1 diabetes."
Related Posts
One in Four Women Globally Experience Intimate Partner Violence
WEDNESDAY, Feb. 23, 2022 (HealthDay News) -- More than one in four...
Outcomes Superior With CABG Versus Multivessel PCI
THURSDAY, Jan. 26, 2023 (HealthDay News) -- Coronary artery bypass grafting...
Las personas inmunocomprometidas quizá necesiten una cuarta dosis de la vacuna contra la COVID, según los CDC
MIÉRCOLES, 27 de octubre de 2021 (HealthDay News) -- Las personas gravemente...
Guideline Developed for Assessing Penicillin Allergies
MONDAY, Oct. 3, 2022 (HealthDay News) -- In a clinical practice guideline issued...